XB-ART-41512
J Pharmacol Exp Ther
2010 Sep 01;3343:917-26. doi: 10.1124/jpet.110.167684.
Show Gene links
Show Anatomy links
Pharmacological characterization of the allosteric modulator desformylflustrabromine and its interaction with alpha4beta2 neuronal nicotinic acetylcholine receptor orthosteric ligands.
Weltzin MM
,
Schulte MK
.
???displayArticle.abstract???
???displayArticle.pubmedLink??? 20516140
???displayArticle.pmcLink??? PMC2939658
???displayArticle.link??? J Pharmacol Exp Ther
???displayArticle.grants??? [+]
1R01NS066059 NINDS NIH HHS , 5P20RR016466 NCRR NIH HHS , P20 RR016466 NCRR NIH HHS , R01 NS066059 NINDS NIH HHS
References [+] :
Adams,
Evidence for a role of nicotinic acetylcholine receptors in schizophrenia.
2007, Pubmed
Adams, Evidence for a role of nicotinic acetylcholine receptors in schizophrenia. 2007, Pubmed
Armstrong, Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. 2000, Pubmed
Armstrong, Tuning activation of the AMPA-sensitive GluR2 ion channel by genetic adjustment of agonist-induced conformational changes. 2003, Pubmed , Xenbase
Aubert, Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. 1992, Pubmed
Bertrand, Allosteric modulation of nicotinic acetylcholine receptors. 2007, Pubmed
Bourin, Nicotinic receptors and Alzheimer's disease. 2003, Pubmed
Briggs, Gain of function mutation of the alpha7 nicotinic receptor: distinct pharmacology of the human alpha7V274T variant. 1999, Pubmed , Xenbase
Celie, Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. 2004, Pubmed
Coe, Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. 2005, Pubmed , Xenbase
Corey-Bloom, Galantamine: a review of its use in Alzheimer's disease and vascular dementia. 2003, Pubmed
Court, Nicotinic receptor abnormalities in Alzheimer's disease. 2001, Pubmed
Friedman, Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists. 2004, Pubmed
Furukawa, Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core. 2003, Pubmed
Galzi, Mutations in the channel domain of a neuronal nicotinic receptor convert ion selectivity from cationic to anionic. 1992, Pubmed , Xenbase
Grønlien, Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes. 2007, Pubmed , Xenbase
Han, Comparison of taurine- and glycine-induced conformational changes in the M2-M3 domain of the glycine receptor. 2004, Pubmed
Hansen, Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. 2005, Pubmed
Harvey, Multiple determinants of dihydro-beta-erythroidine sensitivity on rat neuronal nicotinic receptor alpha subunits. 1996, Pubmed , Xenbase
Hogner, Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core. 2002, Pubmed
Hurst, A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. 2005, Pubmed , Xenbase
Inanobe, Mechanism of partial agonist action at the NR1 subunit of NMDA receptors. 2005, Pubmed , Xenbase
Jin, Structural basis for partial agonist action at ionotropic glutamate receptors. 2003, Pubmed , Xenbase
Joshi, A vertical flow chamber for Xenopus oocyte electrophysiology and automated drug screening. 2004, Pubmed , Xenbase
Kim, Synthesis of desformylflustrabromine and its evaluation as an alpha4beta2 and alpha7 nACh receptor modulator. 2007, Pubmed , Xenbase
Kloda, Agonist-, antagonist-, and benzodiazepine-induced structural changes in the alpha1 Met113-Leu132 region of the GABAA receptor. 2007, Pubmed , Xenbase
Krause, Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. 1998, Pubmed , Xenbase
Lape, On the nature of partial agonism in the nicotinic receptor superfamily. 2008, Pubmed
Lippiello, Nicotinic cholinergic antagonists: a novel approach for the treatment of autism. 2006, Pubmed
Liu, Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors. 2008, Pubmed
Martin-Ruiz, Molecular analysis of nicotinic receptor expression in autism. 2004, Pubmed
Mayer, Glutamate receptors at atomic resolution. 2006, Pubmed
Middlemiss, Centrally active 5-HT receptor agonists and antagonists. 1992, Pubmed
Moroni, alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine. 2006, Pubmed , Xenbase
Nicolson, A prospective, open-label trial of galantamine in autistic disorder. 2006, Pubmed
Nordberg, Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. 2001, Pubmed
Robert, AMPA receptor binding cleft mutations that alter affinity, efficacy, and recovery from desensitization. 2005, Pubmed
Sala, Potentiation of human alpha4beta2 neuronal nicotinic receptors by a Flustra foliacea metabolite. 2005, Pubmed , Xenbase
Stevens, Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. 1998, Pubmed
Woodruff-Pak, Neuronal nicotinic acetylcholine receptors: involvement in Alzheimer's disease and schizophrenia. 2002, Pubmed